Organon (OGN) Operating Income (2020 - 2025)
Historic Operating Income for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $358.0 million.
- Organon's Operating Income fell 820.51% to $358.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 62112.07%. This contributed to the annual value of $169.0 million for FY2024, which is 1985.82% up from last year.
- Per Organon's latest filing, its Operating Income stood at $358.0 million for Q3 2025, which was down 820.51% from $324.0 million recorded in Q2 2025.
- Over the past 5 years, Organon's Operating Income peaked at $390.0 million during Q3 2024, and registered a low of -$579.0 million during Q4 2023.
- In the last 5 years, Organon's Operating Income had a median value of -$220.0 million in 2021 and averaged -$121.6 million.
- As far as peak fluctuations go, Organon's Operating Income tumbled by 49508.2% in 2021, and later surged by 20000.0% in 2024.
- Quarter analysis of 5 years shows Organon's Operating Income stood at -$363.0 million in 2021, then crashed by 33.06% to -$483.0 million in 2022, then decreased by 19.88% to -$579.0 million in 2023, then skyrocketed by 149.74% to $288.0 million in 2024, then grew by 24.31% to $358.0 million in 2025.
- Its Operating Income was $358.0 million in Q3 2025, compared to $324.0 million in Q2 2025 and $239.0 million in Q1 2025.